-
公开(公告)号:US08613914B2
公开(公告)日:2013-12-24
申请号:US13614902
申请日:2012-09-13
IPC分类号: A61K45/00
CPC分类号: C07K7/06 , A61K31/403 , A61K31/4439 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/14 , C07K5/06165 , C07K5/08 , C07K5/0808 , C07K5/0812 , C07K5/10 , C07K5/101 , C07K5/1016
摘要: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的有机化合物。
-
公开(公告)号:US20120015907A1
公开(公告)日:2012-01-19
申请号:US13089764
申请日:2011-04-19
申请人: David BARNES , Rajiv CHOPRA , Scott Louis COHEN , Jiping FU , Mitsunori Kato , Peichao LU , Mohindra SEEPERSAUD , Wei ZHANG
发明人: David BARNES , Rajiv CHOPRA , Scott Louis COHEN , Jiping FU , Mitsunori Kato , Peichao LU , Mohindra SEEPERSAUD , Wei ZHANG
IPC分类号: A61K31/4355 , C07D413/14 , A61K31/5377 , C07D405/14 , A61K31/496 , C07D417/14 , A61K31/541 , A61K31/675 , C07D491/14 , A61K31/55 , C07D498/14 , A61P31/14 , A61P1/16 , A61P35/00 , A61P7/00 , A61P37/04 , C07D491/048
CPC分类号: C07D491/147 , C07D491/048
摘要: The present invention provides a compound of formula I; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
-
公开(公告)号:US20090197856A1
公开(公告)日:2009-08-06
申请号:US12339460
申请日:2008-12-19
申请人: Salvador G. Alvarez , Janos Botyanszki , Joseph de los Angeles , Jiping Fu , Roger Fujimoto , Joshua Michael Gralapp , Ronald Conrad Griffith , Peichao Lu , Son Minh Pham , Christopher Don Roberts , Franz Ulrich Schmitz , Mohindra Seepersaud , Ruben Tommasi , Adam Christopher Villa , Sompong Wattanasin , Aregahagn Yifru , Rui Zheng , Xiaoling Zheng
发明人: Salvador G. Alvarez , Janos Botyanszki , Joseph de los Angeles , Jiping Fu , Roger Fujimoto , Joshua Michael Gralapp , Ronald Conrad Griffith , Peichao Lu , Son Minh Pham , Christopher Don Roberts , Franz Ulrich Schmitz , Mohindra Seepersaud , Ruben Tommasi , Adam Christopher Villa , Sompong Wattanasin , Aregahagn Yifru , Rui Zheng , Xiaoling Zheng
IPC分类号: A61K31/407 , C07D487/14 , A61K31/454 , A61K31/5377 , A61K31/551 , A61K31/5355 , A61K31/496 , A61K31/541 , A61K31/437 , A61P31/12
CPC分类号: C07D471/22 , C07D487/14 , C07D487/22
摘要: Provided are compounds of Formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds and compositions are useful for treating viral infections caused by the Flaviviridae family of viruses.
摘要翻译: 提供式(I)的化合物或其药学上可接受的盐或溶剂化物。 化合物和组合物可用于治疗由黄病毒科病毒引起的病毒感染。
-
公开(公告)号:US20140357551A1
公开(公告)日:2014-12-04
申请号:US14462406
申请日:2014-08-18
CPC分类号: C07K7/06 , A61K31/403 , A61K31/4439 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/14 , C07K5/06165 , C07K5/08 , C07K5/0808 , C07K5/0812 , C07K5/10 , C07K5/101 , C07K5/1016
摘要: The present application describes organic compounds of Formula (II) that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的式(II)的有机化合物。
-
公开(公告)号:US08840878B2
公开(公告)日:2014-09-23
申请号:US13614813
申请日:2012-09-13
IPC分类号: A61K45/00 , C07D417/14 , C07D401/12 , C07D209/96 , C07D401/14 , C07K5/087 , C07K5/078 , C07K5/107 , C07D403/12 , C07D403/14 , C07D405/14 , C07K5/103 , C07K5/083
CPC分类号: C07K7/06 , A61K31/403 , A61K31/4439 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/14 , C07K5/06165 , C07K5/08 , C07K5/0808 , C07K5/0812 , C07K5/10 , C07K5/101 , C07K5/1016
摘要: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的有机化合物。
-
公开(公告)号:US20130022572A1
公开(公告)日:2013-01-24
申请号:US13614902
申请日:2012-09-13
CPC分类号: C07K7/06 , A61K31/403 , A61K31/4439 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/14 , C07K5/06165 , C07K5/08 , C07K5/0808 , C07K5/0812 , C07K5/10 , C07K5/101 , C07K5/1016
摘要: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的有机化合物。
-
公开(公告)号:US08222425B2
公开(公告)日:2012-07-17
申请号:US13185683
申请日:2011-07-19
申请人: Shawn D. Britt , Lech Andrzej Ciszewski , Jiping Fu , Subramanian Karur , Yugang Liu , Peichao Lu , David Thomas Parker , Mahavir Prashad , Prakash Raman , Pascal Rigollier , Mohindra Seepersaud , Aregahegn Yifru , Rui Zheng
发明人: Shawn D. Britt , Lech Andrzej Ciszewski , Jiping Fu , Subramanian Karur , Yugang Liu , Peichao Lu , David Thomas Parker , Mahavir Prashad , Prakash Raman , Pascal Rigollier , Mohindra Seepersaud , Aregahegn Yifru , Rui Zheng
IPC分类号: C07D207/00
CPC分类号: C07D401/12 , C07D403/12 , C07K5/0812 , C07K5/1016
摘要: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的有机化合物。
-
公开(公告)号:US07615635B2
公开(公告)日:2009-11-10
申请号:US11914659
申请日:2006-05-22
申请人: Kathryn Rene Bracken , Simon Bushell , Karl Dean , Charles Francavilla , Rakesh K. Jain , Kwangho Lee , Mohindra Seepersaud , Lei Shu , Arathi Sundaram , Zhengyu Yuan
发明人: Kathryn Rene Bracken , Simon Bushell , Karl Dean , Charles Francavilla , Rakesh K. Jain , Kwangho Lee , Mohindra Seepersaud , Lei Shu , Arathi Sundaram , Zhengyu Yuan
IPC分类号: C07D403/12 , A61K31/501 , A61K31/497 , A61K31/506 , A61K31/4439 , C07D401/12 , C07D309/10 , C07D207/08 , A61P31/04
CPC分类号: C07D401/12 , C07D403/12
摘要: Novel N-formyl hydroxylamine compounds and their derivatives are disclosed. These N-formyl hydroxylamine compounds inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The compounds are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as MMPs. Methods of preparation and use of the compounds are also disclosed.
摘要翻译: 公开了新的N-甲酰羟胺化合物及其衍生物。 这些N-甲酰基羟胺化合物抑制肽原甲酰化酶(PDF),一种存在于原核生物中的酶。 这些化合物可用作抗微生物剂和抗生素。 本发明的化合物显示出对其它金属蛋白酶如MMP的肽基变性酶的选择性抑制。 还公开了化合物的制备和使用方法。
-
9.Derivatised proline containing peptide compounds as protease inhibitors 有权
标题翻译: 含有肽化合物的衍生脯氨酸作为蛋白酶抑制剂公开(公告)号:US08512690B2
公开(公告)日:2013-08-20
申请号:US12755852
申请日:2010-04-07
IPC分类号: A61K45/00
CPC分类号: C07K7/06 , A61K31/403 , A61K31/4439 , A61K38/06 , A61K38/07 , A61K38/08 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D417/14 , C07K5/06165 , C07K5/08 , C07K5/0808 , C07K5/0812 , C07K5/10 , C07K5/101 , C07K5/1016
摘要: The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.
摘要翻译: 本申请描述了可用于治疗,预防和/或改善人类疾病的有机化合物。
-
公开(公告)号:US08445527B2
公开(公告)日:2013-05-21
申请号:US13477866
申请日:2012-05-22
申请人: Michael Patane , Prakash Raman , David Thomas Parker , Jiping Fu , Branko Radetich , Mohindra Seepersaud , Aregahegn Yifru , Rui Zheng , Trixi Brandl , Francois Lenoir , Pascal Rigollier , Oliver Simic
发明人: Michael Patane , Prakash Raman , David Thomas Parker , Jiping Fu , Branko Radetich , Mohindra Seepersaud , Aregahegn Yifru , Rui Zheng , Trixi Brandl , Francois Lenoir , Pascal Rigollier , Oliver Simic
IPC分类号: A61K31/5377 , A61K31/506 , A61K31/497 , A61K31/4439 , A61K31/454 , A61K31/427 , A61K31/422 , A61K31/4178 , A61K31/4155 , A61K31/403
CPC分类号: A61K38/07 , A61K38/00 , A61K38/06 , A61K45/06 , C07D209/96 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , C07D487/10 , C07D491/20 , C07D495/10 , C07D498/04 , C07D498/10 , C07K5/06034 , C07K5/06078 , C07K5/06165 , C07K5/0808 , C07K5/0812 , C07K5/101 , C07K5/1016
摘要: The present invention provides a method of treating a HCV infection in a subject in need thereof by administering a compound of Formula I: or pharmaceutically acceptable salts thereof or stereoisomers thereof.
摘要翻译: 本发明提供了通过给予式I化合物或其药学上可接受的盐或其立体异构体来治疗有需要的受试者的HCV感染的方法。
-
-
-
-
-
-
-
-
-